NCT03018015View on ClinicalTrials.gov

Ibuprofen Bioavailability Trial With Oral Single Dose Administration.

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Bioequivalence
Interventions
DRUG

Ibuprofen 400 mg oral powder

DRUG

Ibuprofen 400 mg film-coated tablet

DRUG

Ibuprofen 400 mg soft capsule

Trial Locations (1)

99084

SocraTec R&D GmbH Clinical Pharmacology Unit, Erfurt

All Listed Sponsors
collaborator

SocraMetrics GmbH

INDUSTRY

lead

SocraTec R&D GmbH

OTHER

NCT03018015 - Ibuprofen Bioavailability Trial With Oral Single Dose Administration. | Biotech Hunter | Biotech Hunter